Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease

NCT01319045 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped enrollment was too slow

Conditions

Pulmonary Arterial Hypertension
Congenital Heart Disease
Eisenmenger's Syndrome

Interventions

DRUG: Iloprost

Sponsor

University of California, Los Angeles

Collaborators

[object Object]